PTEN and prostate carcinoma: To determine whether the hypersensitivity of PTEN-deficient prostate cancer cells to ROS-induced cell death is PI3K/Akt dependent, we first restored PTEN expression in the Pten-deficient cells and silenced Pten in the Pten-proficient cells.